Mucoadhesive electrospun nanofibrous poly(ε-caprolactone)/poly(lactic acid) matrices for the ocular delivery of moxifloxacin: a novel application of hyaluronic acid and xanthan gum blend as mucoadhesive coating agent
Abstract
Abstract The use of ocular inserts (OS) as vehicles for the delivery of antimicrobial agents to the eye is rapidly growing. In fact, the intraOS can deliver the antibiotics to the ocular surface after ophthalmic surgeries i.e., cataract. This was a rational progress of pharmaceutical field given that the conventional dosage forms i.e., drops present many limitations. Considering this fact, in this study novel nanofibrous inserts based on poly(ε-caprolactone) and poly(lactic acid) prepared via electrospinning process and used to load an antibiotic drug, moxifloxacin. The used aliphatic polyesters are biocompatible but do not present mucoadhesion which is essential for ocular drug delivery. Therefore, two known mucoadhesive agents, hyaluronic acid and xanthan gum, were blended in various concentrations (0.1 and 0.2%) and used for the coating of the fibers. The fibrous inserts have mean diameters in the range 500–1000 nm. The inserts showed stability over time, improved water uptake and improved mechanical properties. In vitro cytotoxicity studies revealed the biocompatibility of the structures. From in vitro release studies, a controlled release rate was depicted while the inserts demonstrated desirable antimicrobial properties. It can be concluded that the coated OS can be potent ocular delivery carriers of moxifloxacin battling against eye infections. Graphical Abstract
Read the paper
Related studies
- Synthesis, In Vitro and In Silico Molecular Docking Studies of Novel Phthalimide–Pyrimidine Hybrid Analogues to Thalidomide as Potent Antitubercular Agents
- Exploring the inhibitory performance of expired moxifloxacin and norfloxacin on copper corrosion in saline environment
- Molecular investigation of antimicrobial peptides against Helicobacter pylori proteins using a peptide-protein docking approach
- Screening of novel narrow-spectrum benzofuroxan derivatives for the treatment of multidrug-resistant tuberculosis through in silico, in vitro, and in vivo approaches
- Synthesis, Characterization, Anticancer, Antioxidant, and In Silico Evaluation of Semicarbazides and Thiosemicarbazides
- Fast and accurate prediction of drug induced proarrhythmic risk with sex specific cardiac emulators
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.